Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Amortizatization of Intangibles (2018 - 2023)

Historic Amortizatization of Intangibles for Serina Therapeutics (SER) over the last 6 years, with Q4 2023 value amounting to $33000.0.

  • Serina Therapeutics' Amortizatization of Intangibles changed 0.0% to $33000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $131000.0, marking a year-over-year decrease of 75.76%. This contributed to the annual value of $131000.0 for FY2023, which is 75.76% down from last year.
  • Per Serina Therapeutics' latest filing, its Amortizatization of Intangibles stood at $33000.0 for Q4 2023, which was down 0.0% from $33000.0 recorded in Q3 2023.
  • Serina Therapeutics' Amortizatization of Intangibles' 5-year high stood at $140000.0 during Q2 2019, with a 5-year trough of $5000.0 in Q4 2020.
  • Its 5-year average for Amortizatization of Intangibles is $61700.0, with a median of $33000.0 in 2020.
  • As far as peak fluctuations go, Serina Therapeutics' Amortizatization of Intangibles tumbled by 9640.29% in 2020, and later surged by 56000.0% in 2021.
  • Quarter analysis of 5 years shows Serina Therapeutics' Amortizatization of Intangibles stood at $139000.0 in 2019, then tumbled by 96.4% to $5000.0 in 2020, then surged by 560.0% to $33000.0 in 2021, then changed by 0.0% to $33000.0 in 2022, then changed by 0.0% to $33000.0 in 2023.
  • Its Amortizatization of Intangibles was $33000.0 in Q4 2023, compared to $33000.0 in Q3 2023 and $32000.0 in Q2 2023.